690 - The New Kid On The Block: Use of Maribavir in Pediatric Immunocompromised Hosts

Presenting Author(s)

• 

  Antigone Kraft, MD

  Medical Officer
  Food and Drug Administration
  Silver Spring, MD, United States

  Slides

Co-Author(s)

• MJ

  Madeline Johnson, MPH

  CRA II
  St. Jude Children's Research Hospital
  Memphis, Tennessee, United States
• 

  Gabriela Maron, MD, MS (she/her/hers)

  Member
  St. Jude Children's Research Hospital
  Memphis, TN, United States
• 

  Diego R. Hijano, MD, MSc (he/him/his)

  Associate Member
  St. Jude Children's Research Hospital
  Memphis, TN, United States
• WO

  William R. Otto, MD, MSCE (he/him/his)

  Assistant Professor
  Cincinnati Children's Hospital Medical Center
  Cincinnati, OH, United States
• 

  Lara A. Danziger-Isakov, MD, MPH

  Professor
  Cincinnati Children's Hospital
  Cincinnati, OH, United States
• TS

  Tanvi S. Sharma, MD, MPH (she/her/hers)

  Clinical Director and Associate Chief, Division of Infectious Diseases Program Director, Pediatric Infectious Diseases Fellowship Program
  Boston Children's Hospital
  Boston, MA, United States
• SV

  Surabhi Vora, MD, MPH

  Associate Professor
  Seattle Children's Hospital/University of Washington
  Seattle, Washington, United States
• KN

  Kari Neemann, MD

  Associate Professor
  University of Nebraska Medical Center - Children's Nebraska
  Omaha, Nebraska, United States
• CB

  Claire Bocchini, MD

  Assistant Professor of Pediatrics
  Baylor College of Medicine
  Houston, Texas, United States
• 

  Joana Dimo, DO (she/her/hers)

  Pediatric Infectious Diseases Fellow
  University of Colorado/Children's Hospital Colorado
  Denver, Colorado, United States
• 

  Benjamin Hanisch, MD

  Assistant Professor
  Children’s National Hospital, Washington, DC, USA
  Washington, District of Columbia, United States